Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7901–7950 of 18431
On October 11, 2023, in connection with a management restructuring, Greenidge Generation Holdings Inc. (the “Company”) appointed Christian Mulvihill as its new Chief Financial Officer (“CFO”), succeeding Robert Loughran, who no longer remains with the Company.
appointed Geoffrey Parker as the Company’s Executive Vice President, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer effective October 16, 2023
replacing David M. Chang, M.D., Ph.D. and Jack Chen in their capacities as the Company’s interim principal financial officer and interim principal accounting officer, respectively.
On October 16, 2023, the Board of Directors of the Company appointed Theresa Neri Strong to serve as the Company’s interim Chief Financial Officer effective upon Mr. Walker’s departure.
Mr. Menzo Case, President and Chief Executive Officer of the Company and the Bank, passed away on October 13, 2023.
The Company announced that effective October 16, 2023, Angela Krezmer, the Company’s Chief Financial Officer, has been appointed to serve as the Company’s interim Principal Executive Officer.
Effective October 13, 2023, Shawn M. Guertin, the Executive Vice President and Chief Financial Officer of CVS Health Corporation (“CVS Health,” the “Company,” “we” or “our”), has begun a personal leave of absence for unforeseen family medical reasons.
Appointment of Interim Chief Financial Officer In connection with Mr. Guertin’s leave, the Company’s Board of Directors appointed Thomas F. Cowhey, Senior Vice President, Corporate Finance, to serve as the Company’s Interim Chief Financial Officer, effective October 13, 2023.
On October 10, 2023, the Board of Directors (the “Board”) of Meta Materials Inc. (also referred to herein as the “Company”, “we”, “us”, or “our”) removed George Palikaras as President and Chief Executive Officer (“CEO”) of the Company, effective immediately.
the Board appointed Jim Fusaro as the new CEO of the Company, effective immediately.
the Company notified Ran Daniel, its Chief Financial Officer since 2018, that the Employment Agreement would not be renewed.
On October 11, 2023, the Board of Directors of the Company, based upon the recommendation of its Audit Committee, appointed Shlomo Zakai as the Company’s Chief Financial Officer.
On October 10, 2023, the Board of Directors (the “Board”) of WeWork Inc. (the “Company”) appointed David Tolley as the Company’s Chief Executive Officer (“CEO”) on a permanent basis.
On October 16, 2023, DBV Technologies S.A. (the “Company”) announced the appointment of Virginie Boucinha as the Company’s Chief Financial Officer and principal accounting officer, effective as of November 6, 2023.
In addition, the Company announced that Sébastien Robitaille, who currently serves as the Company’s Chief Financial Officer, will separate employment with the Company effective November 17, 2023 to pursue other opportunities.
Upon such resignations, Ebru Törehan was appointed as Chief Executive Officer, Chairman of the Board, Treasurer and Secretary, and Director of the Company.
On October 12, 2023, the board of directors of the Bionexus Gene Lab Corp. (“the Company”) approved the appointment of Mr. Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12, 2023.
On October 10, 2023, Greg Powell submitted his resignation as Chief Financial Officer of Midwest Energy Emissions Corp. (the “Company”) effective immediately.
the Company appointed Benjamin L. Stilwill as Chief Executive Officer of the Company, effective October 13, 2023.
the Company appointed Bryant “B.J.” Reeves as Interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of the Company, effective October 13, 2023.
Thomas J. Gibson will no longer serve as Chief Financial Officer of the Company, effective October 13, 2023.
On October 16, 2023, Mr. Pak Hong WAN (“Mr. WAN”) resigned his positions as Chief Executive Officer, Chief Financial Officer, President, Treasurer and Secretary and the Chairman of Board of Directors of the Company.
On October 16, 2023, the Company’s Board of Directors appointed Mr. Hoi Sau KOO (“Mr. KOO”), aged 25, to act as the Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and the Chairman of Board of Directors of the Company.
In addition to his resignation from the Company's Board of Directors, Mr. Morales tendered his resignation as the Company's President and Chief Executive Officer effective on October 13, 2023
The Board of Directors of Allogene Therapeutics, Inc. (the “Company”) appointed Geoffrey Parker as the Company’s Executive Vice President, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer effective October 16, 2023.
Tanya Andreev-Kaspin, who has been with the Company since August 22, 2012, and has served as the Company’s CFO since January 1, 2020, will be leaving Innovid to pursue other opportunities.
On October 16, 2023, Innovid announced the appointment of Anthony Callini as the Company’s new Chief Financial Officer (the “CFO”), effective October 16, 2023.
the board of directors of ODEC appointed Mr. Lee as the Interim President and CEO of ODEC, effective September 8, 2023
following the resignation of Marcus M. Harris, our former President and CEO.
On October 2, 2023, Martin Noe Costas was appointed as the new Chief Financial Officer of Boxabl Inc.
On October 13, 2023, the Supervisory Board of Directors (the “Board”) of the Company temporarily appointed Ms. Anne Johnson, the Company’s Chief Accounting Officer (principal accounting officer), to act as the Company’s Interim Chief Financial Officer (principal financial officer) while Mr. Stephen Bardin is on parental leave.
Mr. Guido is assuming the role of principal accounting officer from Mark Webb, the Company’s Executive Vice President and Chief Financial and Operating Officer, who will continue to serve as the Company’s principal financial officer.
On October 12, 2023, the Board of Directors (the “Board”) of Analog Devices, Inc. (the “Company”) appointed James Mollica as interim Chief Financial Officer (principal financial officer), effective as of October 29, 2023, until a successor Chief Financial Officer is named.
Effective October 13, 2023, our Board of Directors has determined to appoint Oliver Foeste as Chief Financial Officer.
Effective October 13, 2023, John Cassels is being replaced as the Chief Financial Officer (“CFO”) of CannPharmaRX, Inc.
As previously reported, Anthony Capone resigned as the Chief Executive Officer of DocGo Inc. (the “Company”) effective September 15, 2023.
On October 9, 2023, Martine Ferland informed Marsh & McLennan Companies, Inc. (the “Company”) of her intention to retire as Mercer’s President and Chief Executive Officer on March 31, 2024.
the appointment of Matthew S. Kissner as interim President and Chief Executive Officer
announcing the departure of Brian A. Napack from the Company
On October 11, 2023, Rahsan-Rahsan Lindsay, the Chief Executive Officer of MediaCo Holding Inc. (the “Company” or “MediaCo”), resigned as an officer of the Company and as a member of the Board of Directors of the Company, both effective on such date.
Mr. Sean Thompson, the Company’s current President & Chief Commercial Officer, is expected to assume the role of Interim CEO upon the effectiveness of Mr. Weston’s resignation.
On the Effective Date, Mr. Brad Weston provided notice of his intention to resign as Chief Executive Officer (“CEO”) of the Company, effective November 3, 2023.
Joanne Merrill was appointed Chief Financial Officer
Cecil D. Magpuri was appointed Chief Executive Officer
Appointment of Stephen Johnston as Chief Financial Officer In connection with the departure of Mr. Orsmond, on October 9, 2023 (the “Start Date”), the Company appointed Stephen Johnston as the Company’s Chief Financial Officer, effective immediately.
Departure of Mark Orsmond as Chief Financial Officer On October 12, 2023, ElectraMeccanica Vehicles Corp. (the “Company”) announced that Mark Orsmond is no longer serving as the Company’s Chief Financial Officer, effective October 9, 2023, and will be departing the Company.
Mr. Vasos succeeds Jeffery C. Owen, whose separation from the Company and resignation as a director was effective earlier on October 12, 2023.
On and effective October 12, 2023, the Board of Directors (the “Board”) of Dollar General Corporation (the “Company”) appointed Todd J. Vasos as Chief Executive Officer of the Company.
John P. Bilbrey has been appointed as interim Chief Executive Officer of the Company, effective as of such date.
JuE Wong, who no longer serves as President and Chief Executive Officer, effective as of October 12, 2023.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.